pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vyome Holdings, Inc ($HIND) · news · pharmadog
← back to Vyome Holdings, Inc
News mentioning $HIND
13
stories
7d
Mirum reports Phase 3 victory for acquired hepatitis D med
endpoints
26d
Key research behind orexin and narcolepsy wins Lasker Award
endpoints
Aug 18, 26
Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy lifting
endpoints
Aug 13, 26
'Incorrect and misleading' data prompted decision to pull Tavneos in Europe
endpoints
Jul 23, 26
What’s behind the proposed pullback on remote patient monitoring
endpoints
Jul 20, 26
House lawmakers back trade probe of China biotech, sequencing
endpoints
Jul 14, 26
Former Akero team announces new I&I company, Avere, with China drug
endpoints
Jul 8, 26
HHS lays groundwork for new FDA rule on releasing CRLs
endpoints
Jun 18, 26
Eli Lilly's TuneLab hits 100 members, adding Chai's AI models
endpoints
Jun 9, 26
Post-Hoc Live: How much is everyone in biopharma getting paid?
endpoints
May 13, 26
Behind Galapagos’ transformation into Lakefront Biotherapeutics
endpoints
May 9, 26
Biotech’s new company model; The super poop behind a startup launch; and more
endpoints
May 5, 26
Microbiome startup raises $48M for immunotherapy and malnutrition treatments
endpoints
